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Abstract
Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus
disease-19 (COVID-19), in December 2019, the infection has spread around the globe. Some of the risk factors include
social distancing, mask wearing, hand washing with soap, obesity, diabetes, hypertension, asthma, cardiovascular disease,
and dysbiosis. Evidence has shown the incidence of total infection and death rates to be lower in sub-Saharan Africa when
compared with North Africa, Europe and North America and many other parts of the world. The higher the metabolic syndrome rate, the higher the risk of SARS-CoV-2 infection. Africa has a lower rate of metabolic syndrome risk than many other
continents. This paradox has puzzled several in the biomedical and scientific communities. Published results of research have
demonstrated the exciting correlation that the combination of young age of the population coupled with their native plantbased diet has lowered their risk factors. The plant-based diet include whole grains (millet, sorghum), legumes (black-eye
peas, dry beans, soybean), vegetables, potato, sweet potato, yams, squash, banana, pumpkin seeds, and moringa leaves, and
lower consumption of meat. The plant-based diet results in a different gut microbiota than of most of the rest of the world.
This has a significant impact on the survival rate of other populations. The “plant-based diet” results in lower rates of obesity,
diabetes and dysbiosis, which could contribute to lower and less severe infections. However, these hypotheses need to be
supported by more clinical and biostatistics data.
Keywords SARS-CoV-2 · COVID-19 · Sub-Saharan Africa · Infection · Young age · Diet

Introduction
Since the initial December 2019 outbreak and spread of the
severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) and COVID-19 worldwide pandemic, the incidence
during the first wave of SARS-CoV-2 infection and COVID19 remained lower in sub-Saharan Africa than many parts of
the world (Fig. 1, Table 1). In both waves, with the exception
of South Africa, the incidence remained remarkably low in
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sub-Saharan African countries compared to Europe, North
America, South America, and India. In most sub-Saharan
African countries, the incidence of SARS-CoV-2 infection
and COVID-19 is confined to major metropolitan areas like
Lagos, Kinshasa, Abidjan, Nairobi, Addis Ababa, Dakar,
Accra, or Bamako. However, despite the dense populations
in Lagos (14,368,000), Kinshasa (14,340,000), Abidjan
(5,203,000), Nairobi (4,735,000), Addis Ababa (4,794,000),
or Dakar (3,140,000), SARS-CoV-2 infectivity is lower
than Sao Paolo with a population of 22,000,000, New York
with a population of 18,804,000, Rio with a population of
13,458,075, London with a population of 9,304,000, or New
Delhi with a population of 30,291,000 [https://coronavirus.
jhu.edu/map.html] (Fig. 1 and Table 1). With the exception
of South Africa, other sub-Saharan African countries have
some of the most poorly equipped healthcare systems and
testing infrastructure for the infection in the world. Public
health experts and the media have tried to explain the puzzling low SARS-CoV-2 infection and COVID-19 pandemic
in most sub-Saharan Africa during the first wave of the
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Fig. 1  SARS-CoV-2 incidence
or total cases (TC), COVID-19
related total death (TD), and
death per million population
(DM) in sub-Saharan African
countries

pandemic [1–4] [https://www.washingtonpost.com/world/
africa/africa-coronavirus-low-cases-deaths/2020/12/10/
e907a1 c2-3 899-1 1eb-a ad9-8 95922 7280c 4_s tory.h tml]. Others predicted that the mortality and morbidity will be higher
from SARS-CoV-2 in sub-Saharan Africa than other parts of
the world because of influx of 2 million Chinese nationals
now living and working in Africa [5]. This is in combination with the widespread of communicable diseases in the
continent [5]. COVID-19-induced mortality in sub-Saharan
Africa was less than 1% of the first global COVID-19-induced mortality [https://coronavirus.jhu.edu/map.html]. By
2021, the continent was estimated to have less than 5% of
the world cases [6]. These observations are puzzling the scientific community around the world. It has been suggested
that the low rate of COVID-19 related symptoms and fatality
in sub-Saharan Africa may be associated with a number of

factors including host genetics, previous exposures to viral
infections, lack of testing, misdiagnosis, relatively high temperatures on the continent, and the young age distributions
of the populations in the region [4, 7].
We hypothesize that the combination of younger age distribution, plant-based diet, and gut microbiota will attenuate the infectivity in the region. South Africa appears to be
an outlier, or the exception to the hypothesis and will be
explained later in this review. To support this hypothesis,
we evaluated current literature on (1) The mechanism of
SARS-CoV-2 infection and potential dietary inhibitors, (2)
The younger age distribution of the sub-Saharan African
population compared to the Americas, Europe, and India as
the major risk factor for SARS-CoV-2 infection and COVID19 onset, (3) Diet and gut microbiota in sub-Saharan Africa
versus dysbiosis as a risk factor for SARS-CoV-2 infection
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Table 1  SARS-CoV-2 incidence or total cases (TC), COVID-19
related total death (TD), and deaths per million population (DM) in
the fifteen most affected countries in the world
Total cases

Total deaths

Country

(TC)

(TD)

Deaths
per million
(DM)

USA
India
Brazil
France
Turkey
Russia
UK
Italy
Germany
Spain
Argentina
Colombia
Poland
Iran
Mexico

33,862,398
26,289,290
15,976,156
5,581,351
5,169,951
4,983,845
4,457,923
4,183,476
3,646,600
3,636,453
3,482,512
3,192,050
2,863,031
2,815,882
2,392,744

603,408
295,525
446,527
108,437
45,840
117,739
127,710
125,028
87,852
79,620
73,391
83,719
72,691
78,194
221,256

1,814
212
2,088
1,668
538
806
1,873
2,071
1,046
1,702
1,611
1,630
1,923
921
1,700

and COVID-19 onset worldwide, and (4) The association of
major risk factors and comorbidities for SARS-CoV-2 and
COVID-19 recently observed in sub-Saharan Africa compared to the rest of the world.

The Mechanism of SARS‑CoV‑2 Infection
and Potential Dietary Inhibitors
SARS-CoV-2 infection occurs when SARS-CoV-2 ladendroplets from an infected person are transmitted to another
individual. SARS-CoV-2 uses serine proteases to prime the
virus and allow the virus to attach to the receptor angiotensin converting enzyme-2 (ACE2). The ACE2 receptor
is expressed at high levels in nasopharynx, alveolar type II
cells in the lungs, as well as on myocardial cells, esophagus
keratinocytes, intestinal (ileum and colon) epithelial cells,
kidney, pancreas, bladder urothelial cells, nervous system,
and skin epithelial cells. Inhibiting the binding of the virus
to the cell receptor prevents development of the infection.
If the virus is successful in attaching to the cell receptor
after being primed/activated or after endocytosis the virus
is able to penetrate the cell, replicate, resulting in the cascade of events, cause COVID-19. Trypsin-like proteases
are commonly found in the respiratory tract [8]. High levels
of ACE2 receptors are found in the respiratory tract which
combined with serine proteases facilitate priming and binding of SARS-CoV-2 to the tissues. The severity of COVID19 can be exacerbated by old age, obesity, diabetes, hypertension, cardiovascular disease, kidney disease, asthma,

allergies, compromised immune system, and dysbiosis.
Individuals with these conditions have impaired endothelial
cells, dysbiosis, pre-existing systemic low-grade inflammation, increased expression of SARS-CoV-2 entry receptors
including ACE2 and CD147, and elevated levels of serum
proteases. For example, transmembrane protease serine 2
(TMPRSS2) that can catalyze SARS-CoV-2 activation [9].
Strategies to inhibit proteases that prime the SARS-CoV-2
virus for entry into the host cells are targets for nonvaccine or antiviral treatment for COVID-19 until newly introduced vaccines prove their efficacies [10]. These priming
proteases may be inactivated by bioactive compounds found
in foods that most sub-Saharan Africans consume. Below
is the analysis of the association of SARS-CoV-2 infection
and COVID-19 risk factors and infection incidence, disease
onset, and mortality in sub-Saharan Africa.

The Age Distribution of the Sub‑Saharan Africa
Population as Major Risk Factor for SARS‑CoV‑2
Infection and COVID‑19
SARS-CoV-2 severely infects elderly people (age 55 years
and older), and manifestations of the COVID-19 infection is often more severe in elderly population regardless
of race. Immunosenescence or impaired immune response
is observed in the elderly more than young people. Japan
has an older population distribution compared to the rest
of the world. Throughout the first wave of the COVID-19,
Japan where masks have been extensively used, reported
lower infection and death rate among its old population than
similar old populations in Asian countries. The Japanese
populations used face masks more extensively than other
Asian countries and Western nations where masks were not
used before the pandemic [11]. Twenty-three percent of the
Italian population is 65 years old or higher and Italy has one
of the highest COVID-19 infection rate since the spring of
2020 [12]. Old age is a major risk factor for SARS-CoV-2
infection and severe COVID-19 because dysbiosis and
reduced microbiota diversity are frequent in old people and
predisposes these populations to COVID-19 severity. Older
people in general throughout the world are at higher risk of
SARS-CoV-2 infection and COVID-19 than younger people.
The population distribution in sub-Saharan Africa does not
have as many elderly people as the countries in the rest of
the world. The median age of the population in sub-Saharan
Africa is estimated at 19.7 years [13]. The median age of
the population in South Africa, Laos, Italy, Belgium, Brazil,
and Canada, is 28, 24, 47, 41, 33, and 41 years, respectively https://www.indexmundi.com/. As seen in Fig. 1 and
Table 1, the death rate in the Democratic Republic of Congo,
Uganda, Rwanda, or Burundi is much lower than in Italy,
Brazil, or Mexico. Young people have stronger immune system than older adults, may develop symptomatic or mild
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infection that may be undetected until resolved [13]. SARSCoV-2 infection in young adults is not associated with the
loss of ACE anti-inflammatory and anti-oxidative activity.
As a result, young patients do not present with acute respiratory distress syndrome (ARDS) as do old people.

Diet and Dysbiosis in Sub‑Saharan Africa vs
Dysbiosis as a Major Risk Factor for SARS‑CoV‑2
Infection and COVID‑19
In sub-Saharan Africa, the staple diet is rich in plant-based
diets including whole grains (millet, sorghum), legumes
(black-eye peas, dry beans, soybean), vegetables, potato,
sweet potato, yams, squash, banana, pumpkin seeds, and
moringa leaves, and lower consumption of meat [14]. The
plant foods are excellent sources of protease inhibitors
including the trypsin and trypsin-chymotrypsin inhibitors,
that are bioavailable and can prevent SARS-CoV-2 from
attaching to the host cells [15]. Some of these plant foods
such as the squash are also excellent sources of protease
inhibitors that can help prevent blood clotting, a death causing factor in COVID-19 [16]. Major bean (Phaseolus) consuming countries in the world include Rwanda, Uganda,
Tanzania, Burundi, and Costa Rica. As of May 22, 2021,
the corresponding populations, confirmed cases of COVID19, and COVID-19 related deaths were 12.3 million; 26,602;
349 in Rwanda, 46.13 million; 43,370; 350 in Uganda,
59.7million; 509; 21 in Tanzania, 11.9 million; 4,451; 6
in Burundi, and 5.0 million; 299,219; 3,765 in Costa Rica,
respectively [https://c oronavirus.j hu.e du/m ap.h tml]. In
Uganda, Rwanda, and Burundi, colored beans are eaten
three times a day in almost every household. The health
benefits of cooked beans cannot be overstated. The protease
inhibitors found in dry beans are also present in soybean and
soy products. Major soymilk consuming countries include
Hong Kong, Singapore, Thailand, China, and Malaysia. As
of May 22, 2021, Hong Kong with 14 million population
had 11,830 confirmed COVID-19 cases, and 210 COVID-19
related deaths. Singapore with 5.7 million people had 61,770
confirmed cases and 32 deaths. Thailand with 69.8 million
people had 126,118 confirmed cases, and 759 deaths. China
with 1.43 billion people, had 90,954 confirmed cases and
4,636 deaths. Malaysia with 32.5 million people, 498,796
confirmed cases, and 2,149 deaths [https://coronavirus.jhu.
edu/map.htm]. Major tofu consuming countries include
China, Japan, South Korea, Vietnam, and Philippines. China
with a populations, of 1.43 billion had 90,954 confirmed
cases, and three deaths per million. Japan had 126.3 million;
people, 704,159 confirmed cases and 96 deaths per million.
South Korea had 51.7 million people, 135,344 confirmed
cases and 38 deaths per million. Vietnam had 97.5 million,
41 confirmed cases, and 0.4 deaths per million. The Philippines had 108,900 million people, 1,171,403 confirmed
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cases and 178 deaths per million [https://www.worldomete
rs.info/coronavirus/?utm_campaign=instag ramcoach1].
Laos with a population of 7.3 million had 1,763 confirmed
COVID-19 cases and 2 COVID-19 related death. Cambodia has a population of 16.8 million, 24,157 cases, and 165
COVID-19 related death. TMPRSS2 gene expression is
reduced by the isoflavone genistein which is prevalent in soy
products including soymilk, tofu, miso, and soy flour [17].
TMPRSS2 gene is more highly expressed in Caucasians than
Asians or African men [18]. In summary, countries with
high per capita consumption of dry beans or soy products
have shown low infection and death rate.
Banana (Musa species) is a major staple in Uganda,
Rwanda, and many other countries. Africans consume 21 kg
of banana and plantain per capita while the world per capita
is about 11.7 kg. In Uganda, the per capita for banana and
plantain is 191 kg [https://www.iita.org/]. As of November
14, 2020, Uganda had 46.13 million people, 15,402 confirmed cases and 144 deaths. Rwanda had 12.3 million people, 5,362 confirmed cases and 42 deaths. Burundi had 11.9
million people, 624 confirmed cases and 1 death. Unripened
or ripened bananas contain an inhibitor of trypsin, chymotrypsin, and papain, and a heat-stable inhibitor of ACE [19,
20]. Banana is a whole-fruit which provides prebiotics and
in vitro data show that banana powder can produce antiinflammatory postbiotics short chain fatty acids (SCFA)
including acetate, propionate, and butyrate [21].
Sweet potato (Ipomoea batatas) is heavily consumed
in Nigeria, Tanzania, Ethiopia, and Angola. As of May 22,
2021, populations, confirmed cases, and deaths in these
countries were respectively 207.5 million; 165,944; 2,067,
58.73 million; 509; 21, 114.96 million; 268,520; 4,060, and
32.86 million;31,909; 709 [https://www.worldometers.info/
coronavirus/?utm_campaign=instagramcoach1?].
Sporamin A and B are the major storage proteins in sweet
potato and endowed with a defense role as a Kunitz trypsin
inhibitor [22]. Sweet potato also contains anti-coagulants
coumarins, scopoletin, aesculetin, and umbelliferone. Purple
sweet potato is a good source of pelargonidin, an anticoagulant phenolic compound [23].
Yam (Dioscorea) is mostly consumed in West, Central,
and East Africa. Dioscorin is the major yam storage protein
and is a low temperature stable inhibitor of trypsin [24].
Yam is a good source of dietary fiber for SCFA production
in the gut [25]. The low infectivity and death incidence in
African countries including Uganda, the Democratic Republic of Congo, and Ivory Coast may be explained in part by
high consumption of combination of yams, beans, melon and
pumpkin seeds, and sorghum. All these plant foods are very
rich in trypsin inhibitors and when cooked at temperature
below 100 ℃, these foods preserve the trypsin inhibitory
activity.
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When minimally processed, the foods mentioned above
can be good sources of bioactives including the Kunitz
trypsin inhibitor, cystatin, and cathepsin inhibitors that can
inhibit SARS-CoV-2 infection [15, 16]. The plant bioactives
mentioned above can stand high temperature of 100 ℃ for
5–10 min but are heat stable at lower temperatures. In Africa,
most foods are boiled and not canned or retorted at 121 ℃.
The bioactive proteins in the legumes are anti-inflammatory
and health-enhancing [26]. Beans are excellent sources of all
the proteases mentioned early. Colored beans are also good
sources of pelargonidin known for its in vivo antithrombic
and antiplatelet properties [27]. Polyphenols in colored Phaseolus beans inhibit DPP4, α-amylase, α-glucosidase, and
reactive oxygen species making colored beans a good food
for diabetics who are at risk of SARS-CoV-2 infection [28].
Plant protease inhibitors prevent obesity [29] and inhibit
enzymes associated with chronic diseases invasion and proliferation [30]. These plant-based foods are good sources of
protease inhibitors and anticoagulants.
Dysbiosis is the imbalance in favor of maladaptive and
pathogenic bacteria in the host gut microbiota. Dysbiosis
is significantly associated with all the identified major risk
factors for COVID-19 including old age, obesity, diabetes,
hypertension, cardiovascular disease, and compromised
immune system [31]. Dysbiosis contributes to the course of
COVID-19 because 70 to 80% of the body immune system
is in the gastrointestinal tract and the immunological health
of the gut that is reflected by the gut microbiota influences
lung health through gut-lung axis [32]. Dysbiosis results
in uncontrolled intestinal inflammation, a compromised
immune system which exacerbates COVID-19. Dysbiosis
increases gut permeability and the leakage of pro-inflammatory lipopolysaccharides and pro-inflammatory cytokines in
the blood that can exacerbate the cytokine storm and organ
failure. Short or long-term consumption of diet that consists
of high-fat, high meat fat and proteins, high reducing sugars,
and low plant-based proteins and fiber, rapidly and reproducibly alters the human gut microbiome, causes the disruption of gut microbiota homeostasis, and develops dysbiosis
[33]. The distribution and dominance of microbiota in the
diet are rapidly altered by changes in diet. Dysbiosis significantly affects severe COVID-19 patients. Dysbiosis is cause
and consequence of COVID-19. The GI tract is exposed to
any pathogen or antigen that is introduced into the respiratory system suggesting that SARS-CoV-2 virus that enters
through the nose can also move to the gastrointestinal tract
[34]. Both the lung and gastrointestinal tract are major sites
of ACE2 receptors. In the lungs, following attachment of
SARS-CoV-2 to ACE2-rich cells and endocytosis, if viral
clearance is impaired, the immune system progresses
towards cytokine release and cytokine storm. Enterobacteriaceae, a family of pathogenic bacteria found in gut dysbiosis were identified in the lungs from diseased COVID-19
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patients [35]. This suggests that cytokines released by these
bacteria in the lungs are similarly released in the gut and
the gut-lung axis exacerbates disease severity in individuals
with gut dysbiosis and co-morbidities.
To support the plant-based diet and gut microbiota
hypothesis of low SARS-CoV-2 infectivity in sub-Saharan
Africa, recent findings on gut microbiota of sub-Saharan
Africans may hold some explanation. De Filippo et al.
(2010) investigated and compared human intestinal and
fecal microbiota from European children from urban area
of Florence, Italy and age-matched children from a rural
African village of Burkina Faso [36]. The children from
rural Burkina Faso somehow represented the children in
most rural settings in sub-Saharan Africa while the children
from Florence represented those in most Western countries’
settings. By using high throughput 16 rDNA sequencing and
other biochemical analyses, De Filippo et al. found high
levels of Bacteroidetes and very low levels of Firmicutes
and abundance of Prevotella and Xylanibacter bacteria and
more anti-inflammatory short chain fatty acids in the gut of
Burkina Faso children than the Italian children [36]. Gut
microbiome composition of people living on plant-based
diet in sub-Saharan Africa and profiled through 16SrRNA
gene analysis using 454- pyrosequencing of stool analyses
revealed a higher gut microbiota diversity dominated by
Actinobacteria (Bifidobacterium); Bacteroidetes (Bacteroides–Prevotella); Firmicutes (C. histolyticum, Eubacterium, Oscillibacter, Butyricicoccus and Sporobacter); Proteobacteria (Succinivibrio, Shigella and Escherichia) and
Spirochaetes (Treponema) and depleted in only Actinobacteria (Bifidobacterium catenulatum), Firmicutes (Clostridium
difficile and Akkermansia muciniphila [37, 38]. Meanwhile
the gut microbiota of people in western countries showed
abundance of Firmicutes (Blautia, Dorea, Roseburia, Faecalibacterium, Ruminococcus, Oscillospira, C. perfringens,
C. difficile and S. aureus); Bacteroidetes (Bacteroides), Actinobacteria (B. adolescentis and B. catenulatum) and Verrucomicrobia (A. muciniphila)[38]. The presence of a highly
diverse microbiota in sub-Saharan African populations who
consume plant-based diet was confirmed by Vipperla and
O’Keefe who showed the prevalence of Prevotella in the gut
microbiome of the Africans compared to Africa- American
whose gut microbiota was dominated by Bacteroides [39].
Diet has a major effect on the composition of the gut
microbiota. The diet in Burkina Faso and many other subSaharan African countries is mostly plant-based using whole
grain (millet, sorghum), legumes (black-eye peas, dry beans,
soybean), vegetables, and little meat. The plant-based diet
is rich in protease inhibitors, fiber, prebiotics, phenolic
compounds, minerals, all of which improve gut health. The
fiber, prebiotics, and phenolics are fermented in the colon
to produce anti-inflammatory short chain fatty acids acetate,
butyrate, and propionate, and urolithins. In Florence, the
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children consume typical western diet associated with high
consumption of animal protein and fat, refined starch, reducing sugars, and low in plant-based ingredients. In recent
work, De Filippo et al. showed that when Africans move
from rural areas to major cities and adopt the Western type
of diet, the gut microbiota profile changes with progressive reduction in anti-inflammatory short chain fatty acids
such as butyrate and propionate [40]. The rate of dysbiosis and COVID-19 is higher in major sub-Saharan African
urban areas than rural areas. SARS-CoV-2 infectivity and
COVID-19 is high in African- Americans and low in subSaharan Africans. The high infection and fatality rates in
South Africa can in part be explained by the high levels of
processed foods including sweets and animal products and
less unprocessed plant-based diet consumed in the country unlike other sub-Saharan African countries [41]. As a
result, obesity, diabetes, hypertension, and other noncommunicable chronic degenerative diseases are higher in South
Africa compared to the rest of the sub-Saharan Africa. The
higher the metabolic syndrome rate, the higher the risk of
SARS-CoV-2 infection and COVID-19 development. Regular consumption of properly processed plant-based diet
will improve gut microbiota and attenuate SARS-CoV-2
infection.

The Association of Major Risk Factors
for SARS‑CoV‑2 Infection and COVID‑19 and Current
field Results in Sub‑Saharan Africa
Social Distancing, Mask Wearing, and Hand Washings
with Soap
Social distancing, quarantine, mask wearing, and frequent
hand washings with soap are the best practices to reduce
the spread of SARS-CoV-2 infection. When these protective measures fail, COVID-19 has an increased likelihood
of onset and progression. Densely populated areas are risk
factors for rapid and uncontrolled SARS-CoV-2 infection
dissemination and COVID-19 onset and propagation. Lagos,
Kinshasa, Abidjan, Nairobi, Abuja, or Dakar are densely
populated, yet these cities have lower rate of infectivity than
comparable cities across South America, Europe, North
America, and Asia with similar or high/dense populations.
The second wave of COVID-19 that started in November
2020 has been reported to be associated with an increase in
the rate of infection, yet the total infection and death rates
in Africa are insignificant compared to total infection and
death rates in Western Europe and North America (Fig. 1
and Table 1). Comparisons of results during the first wave
and the second wave show that Sub-Saharan Africa still has
a low rate of SARS-CoV-2 infection and COVID-19 related
death (Fig. 1 and Table 1). In most African major cities,
people are not abiding to social distancing, quarantine, mask
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wearing, and frequent hand washings with soap because
most people work in informal business and cannot sustain a
day without work [42–45].
Obesity
Obesity is a major risk factor for severe SARS-CoV-2 infection and COVID-19. SARS-CoV-2 severely infects obese
subjects more than lean individuals [46, 47]. Diet-induced
metabolic alterations including obesity play a significant role
in the incidence and severity of COVID-19[48–50]. Adipose
tissue is a key endocrine organ that secretes a plethora of
factors including adipokines, chemokines, and cytokines that
profoundly impact metabolism and immune system. Acute
inflammation from COVID-19 may amplify existing chronic
inflammation secondary to obesity and lead to more severe
disease and poorer outcomes [51]. Furthermore, metabolic
changes associated with obesity such as insulin and leptin
resistance negatively impact immune cell function. All these
changes substantially influence the immune cell growth and
proliferation and affect glucose metabolism and activation
which ultimately results in impairment of host immune
defense.
Although lung ACE2 is a major target for SARS-CoV-2
infection, the higher expression of ACE2 gene expression
in human visceral and subcutaneous adipose tissue than
human lung makes obese individuals more vulnerable to
the infection and disease than lean individuals [52]. Obese
individuals have higher levels of interleukin-6 (IL-6), tumor
necrosis factor-alpha (TNF-α), ACE2 on adipocytes, leptin,
lower concentration of adiponectin, hyperactivated mechanistic target of rapamycin (mTOR), natural killer cells polarized to non-cytotoxic, all of which can increase the duration
of SARS-CoV-2 shedding [47]. SARS-CoV-2 virion from
obese individuals is higher than virion from old people than
virion from individuals with cardiovascular disease than
virion from individuals with lung disease than virion from
individuals with diabetes than virion from individuals with
hypertension than virion from smokers than virion from
healthy individuals and the size of virion is associated with
the odds of developing severe viral infection [53]. The BMI
of severe COVID-19 patients median have been reported to
be higher than the BMI of non-severe patients. Obese individuals are prone to excessive oxidative stress, diminished
airway flow, and severe obese individuals are at risk of heart
failure. Like the rest of the world, Sub-Saharan Africa is
experiencing a rise in obesity because of increased urbanization, westernization of lifestyle, decreased physical activity,
increased sedentary lifestyle, and less consumption of fruits
and vegetables but high overindulgence on energy-dense
processed foods in urban areas [54]. Descriptive data analysis of obesity prevalence by country showed higher adult
obesity values in the Americas and Europe and lower values
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in Asia and Africa [55]. Several studies have observed the
higher incidence of adult overweight and obesity in urban
areas compared to rural regions of sub-Saharan Africa. [56].
While the incidence of obesity is increasing in major African cities, it is low (< 5% of its population) compared to
the West or South East Asia. https://worldpopulationreview.
com/c ountr y-r ankin gs/m
 ost-o bese-c ountr ies. With 1.038 billion people, sub-Saharan African has less than 30 million
obese compared to Brazil which has more than 70 million
obese people (33.5% of its population of more than 211 million people). The prevalence of obesity in US was 42.7%
in 2017–2018 [www.cdc.gov] and about 28% in Canada in
2017 [https://obesitycanada.ca/guidelines/epidemiology.
Accessed 1/26/2021]. India alone with 1.353 billion people
has 5 million obese. China with 1,393 billion people has
about 70 million obese. SARS-CoV-2 infectivity spreading,
and fatality is higher in Europe, North America, Brazil, UK,
and Mexico where obesity with median BMI > 25 kg/m2 is
also highly prevalent [47]. Obesity is a major risk factor for
severe SARS-CoV-2 infection and COVID-19 even in young
people. SARS-CoV-2 infectivity and COVID-19 incidence
are higher in major African cities than in the rural areas in
part because processed diet-induced obesity is prevalent in
urban areas than rural [41]. Mean BMI in Africa is < 22 kg/
m2 [57]. The level of physical activity is higher in rural
sub-Saharan African villages than in metropolitan African
cities [58]. The interpersonal contacts are higher between
dwellers of major sub-Saharan African cities and populations from countries with high infection rates than between
rural African populations and populations external to the
African region.
Diabetes
Diabetes is a major comorbidity risk factor for severe SARSCoV-2 infection. Diabetic patients, especially those with
uncontrolled blood glucose, are at greater risk for developing severe COVID-19 disease than healthy individuals.
About 98% of adults with type 2 diabetes carry at least one
or two comorbidities including hypertension, overweight/
obesity, chronic kidney disease, or cardiovascular disease
[59]. Each of these comorbidities is by itself a risk factor
for severe COVID-19 outcome. The hyperglycemic environment of diabetic blood increases glucose secretion within
the airway and promotes immune dysfunction by damaging neutrophil function, repressing the protective antioxidant/anti-inflammatory system and the humoral immunity,
causing micro- and macro-angiopathies, neuropathy, and
reducing the antibacterial activity of urine. Diabetes triggers a pro-inflammatory cytokine environment in the body
associated with high levels of IL-6 and C-reactive protein.
ACE2 is expressed at lower levels in the pancreas, kidneys,
vascular system, and lungs of individuals with diabetes.
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Consequently, these individuals have reduced anti-inflammatory and anti-oxidative capabilities. All these alterations
including compromised glycemic status, innate immune system, and humoral immunity inhibit resistance to any infection including SARS-CoV-2 infection. The interaction of
SARS-CoV-2 with pancreatic ACE2 may lead to β-cell dysfunction-induced hyperglycemic state causing acute diabetes
state [60]. Ex-vivo study has shown that lung monocytes and
macrophages of COVID-19 infected people are highly glycolytic, facilitate SARS-CoV-2 replication and cytokine production. These changes initiate mitochondrial reactive oxygen species production and stabilizing the hypoxia-inducible
factor-1 α (HIF-1α) [61]. HIF-1α-induced metabolic alterations in COVID-19 infected monocyte increase glycolysis
and cytokine such as IL-1β production which drives T cell
dysfunction and lung epithelial cell death. Increased circulating glucose levels in CoV-2 infected monocyte can promote T cell dysfunction and lung epithelial cell apoptosis
in a mitochondrial-ROS/HIF-1α-dependent manner [61].
In sub-Saharan Africa, the prevalence of type 2 diabetes in
adults older than 55 years is about 13% and higher in urban
than rural settings [62]. While individuals with diabetes
are at increased risk arising from severe complications of
SARS-CoV-2, there are less people with diabetes in Africa
(an estimated 15.5 million out of 1.2 billion people) [63]
than China (about 110 million patients out of 1.4 billion
people) than India (an estimated 120 million people out of
1.35 billion people) [64]. There are about 34 million people
with diabetes in the US (about 10% of the population) [www.
cdc.gov].
Hypertension
SARS-CoV-2 severely infects individuals with high blood
pressure who display more than three-fold higher mortality
and short-term mortality rate than normotensive individuals
[65]. One potential mechanism of the contribution of hypertension to severe COVID-19 is as follows. Plasminogen activator inhibitor-1 (PAI-1) levels are high in hypertension,
old age, obesity, diabetes, and cardiovascular disease [66].
Severe COVID-19 develops hypoxia in the lungs. Hypoxia,
through hypoxia-inducible factor-1 alpha (HIF-1α), stimulates the production of PAI-1 in the lung [67]. Injury in the
lungs of SARS-CoV-2 infected individuals leads to overproduction of hyaluronan and the latter also leads to production of more PAI-1. Excessive PAI-1 binds to toll-like
receptor 4 (TLR4) on macrophages, activates NF-κB which
in turn induces the secretion of pro-inflammatory cytokines
and chemokines in the lungs of severely ill patients with
COVID-19. The up-regulation of PAI-1 leads to coagulopathy characterized by intravascular thrombi [66]. The incidence of sequelae of uncontrolled hypertension, specifically
stroke and hypertension heart disease, is greater in Africa
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than in many other parts of the world [68]. Hypertension
afflicts about 46% of African adults aged 25 years and older
[69]. There were 130 million African adults with hypertension in 2010 and the number is expected to increase to 220
million by 2030 [69]. Awareness for hypertension is < 30%,
treatment < 20%, and control rate < 10% [69]. However,
the rate of SARS-CoV-2 infection is low in this part of the
world. SARS-CoV-2 infectivity and COVID-19 is low in
Africa. In sub-Saharan Africa, COVID-19 severity and
fatality have shown discordant association with the disease
comorbidity risk factors including hypertension, diabetes,
and cardiovascular disease whereas in North African countries such as Algeria and Egypt a positive association was
established between the disease severity and the risk factors
[70]. COVID-19 outcome in Africa may be associated with
the modulation of the renin–angiotensin–aldosterone system
(RAAS) axis, which controls ACE/ACE2 balance, in the
region [70].
Cardiovascular
Pre-existing cardiovascular disease such as coronary heart
disease is a comorbidity factor for severe COVID-19 outcomes. Globally speaking, cardiovascular disease disproportionately affects sub-Saharan Africans where the affected
are younger, female, hypertensive and are chronic smokers
[68]. Despite high prevalence of hypertension and smoking, SARS-CoV-2 infectivity and COVID-19 pandemic are
low in the observed sub-Saharan African population. SARSCoV-2 infected patients with pre-existing cardiovascular disease are a greater cardiac failure than healthy individuals.
There is a discordant pattern between the high prevalence of
cardiovascular disease in sub-Sahara Africa and COVID-19
severity and fatality [70].
Asthma in Sub‑Saharan Africa, SARS‑CoV‑2 Infection,
and COVID‑19
Asthma is a risk factor for severe COVID-19 outcomes
because asthmatics have deficient and delayed innate antiviral immune responses, and deficient and delayed lung cell
interferon (IFN)‐α, IFN‐β, and IFN‐λ responses. SARSCoV-2 infection, like asthma, induces an attenuated IFN-I
and INF-III signature and therefore SARS-CoV-2 and the
resultant unopposed TH2 response exacerbates asthma
[71]. Asthma has an estimated high prevalence of 12% in
Africa [72]. Gut and lung dysbiosis are increasingly being
associated with the incidence and severity of asthma [73].
In sub-Saharan Africa, gut dysbiosis is more prevalent in
urban populations than rural ones. Similarly, asthma is
more prevalent in urban populations than rural populations.
A positive dose–response association between consumption of fast foods three times or more in a week and asthma
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and allergies was found in urban areas of South Africa [74].
However, SARS-CoV-2 infectivity and COVID-19 are low
in sub-Saharan Africa.

Conclusion
The correlation between the administration of the Bacille
Calmette-Guérin (BCG) vaccine for tuberculosis and SARSCoV-2 infection and COVID-19 severity is striking [75].
It is not known whether exposure to BCG directly reduces
SARS-CoV-2 infectivity or not, however several studies have shown relatively low SARS-CoV-2 infections in
countries that implemented universal BCG vaccinations
(including most sub-Saharan African countries, Japan, India,
Afghanistan, Nepal, Bhutan, Bangladesh, Israel, and others)
and high infections and mortalities in countries that have
BCG immunization programs only for high-risk communities (USA, Canada, Italy, Spain, France, Germany, South
Korea, Iran) [75]. However, American Indians, Alaskan
natives, India, and Brazil’s BCG adherence does not seem
to support the high SARS-CoV-2 infection and COVID-19
mortality rate in these communities [75] [https://w
 ww.w
 orld
ometers.info/coronavirus/]. The prevalence of co-morbidities including diabetes and obesity in American Indians and
Alaskan natives, diabetes in India, and obesity and diabetes
in Brazil may explain the inefficacy of the BCG vaccine
against these SARS-CoV-2 co-morbidities in these populations. Others have suggested that the nonspecific effect
of the BCG vaccine over the immune system is unknown
and needs to be tested appropriately [76]. COVID-19 can
have serious post-disease side effects, which underline
the benefits of preventive efforts over aggressive management of the disease. Plant-based diet rich in inhibitors of
SARS-CoV-2 infection may reduce the severity of infection and be a bridge to an effective vaccine. The strength of
the hypothesis put herein includes the association between
plant-based diet and reduced dysbiosis and the young age in
the region, which together can help reduce infectivity in the
event of contact with populations from regions with high
infection rate. However, this hypothesis needs to be reported
and then tested through well designed clinical studies and
biochemical analyses to determine the potential correlation
between youth and plant protease inhibitor-rich diet and the
low SARS-CoV-2 infectivity and COVID-19 in sub-Saharan
Africa. The landscape of COVID-19 is evolving very fast to
the point that current efforts are merely and mostly invested
into managing clinical outcomes. Later, during the postCOVID-19 vaccine era, there will be a need in due course,
for reflection for consolidating food science and nutrition
potential contributions to the prevention and management
of SARS-CoV-2 infection and COVID-19. The COVID-19
pandemic is a public health concern that affects and requires
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the contribution of food science and nutrition to this medical
problem. The landscape of the disease risk factors underscores the importance of bringing food scientists and nutritionists onboard with the medical community to find effective solutions for preventing and managing the pandemic.
This hypothesis has limitations. The data analyzed were
from publicly available literature database including PubMed. The hypothesis assumes homogenous rural and urban
populations and behavior across the sub-Saharan African
region throughout the pandemic state although each country
has socio-economic characteristics which may not equally
overlap with other countries in the region. The discovery
of new variants of the virus in the United Kingdom, South
Africa, and Brazil which has already been detected in Canada, the US, and South Korea may bring about different
response from the populations that have been resistant to
the first wave of the virus. However, continuous use of social
distancing, hand washings with soap, face masks, and plantbased rich diet will help prevent and reduce the spread of
the infection.
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